PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Jul-2022 CD BioSciences Introduces Structural Characterization Services to Advance Kinase/Phosphatase Biology Research CD BioSciences
04-Jul-2022 Amerigo Scientific Launches Anex® Brush for Optimal Sampling Amerigo Scientific
04-Jul-2022 CD BioSciences Introduces New GPCR Purification Service for GPCR Research and Drug Development CD BioSciences
04-Jul-2022 CD BioSciences to Offer Cell Death Solutions to Advance Life Science Research CD BioSciences
04-Jul-2022 STEMart Introduces New Antibiotic Potency Tests for Medical Devices STEMart
04-Jul-2022 CD Bioparticles Expands Lipid System Portfolio by the Launch of Sphingolipids CD Bioparticles
04-Jul-2022 Creative Diagnostics Introduces New Cell-based ELISA Services Creative Diagnostics
04-Jul-2022 CD Bioparticles Announces the Launch of Colored Polystyrene Particles CD Bioparticles
04-Jul-2022 Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research Creative Diagnostics
01-Jul-2022 CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service CD ComputaBio
01-Jul-2022 Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay Creative Proteomics
01-Jul-2022 Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service Creative Proteomics
01-Jul-2022 Creative Proteomics Metabolomics Expands Service Offering with the Launch of Food Metabolomics Service Creative Proteomics
01-Jul-2022 Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022 Avantor
30-Jun-2022 Santhera Updates on Ongoing NDA Submission for Vamorolone Santhera
30-Jun-2022 Positive data from the clinical phase I MAD study with AlzeCure's Alzheimer's project NeuroRestore ACD856 MAD
30-Jun-2022 NICE publishes FAD recommending the use of Adtralza®▼(tralokinumab) NICE
30-Jun-2022 Phacilitate announces the inauguration of First Gala Awards Dinner to celebrate the achievements of the advanced therapies field Phacilitate
30-Jun-2022 Amolyt Pharma Strengthens Leadership Team with Appointment of Mark Sumeray, M.D., as Chief Medical Officer Amolyt Pharma 
30-Jun-2022 Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease